H.R. 9260 119th Congress
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
- Economics and Public Finance
- Sponsor: Rep. Aderholt, Robert B. [R-AL-4]
- Congress.gov ↗
Latest action, Jun 11, 2026: Placed on the Union Calendar, Calendar No. 604.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
Sponsor
Sponsored by Rep. Aderholt, Robert B. [R-AL-4] (Republican). No cosponsors.
Referred to: House: Appropriations Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
3M COMPANY
2 reports
ACTION NOW INITIATIVE, LLC
LEWIS-BURKE ASSOCIATES, LLC
2 reports
ACTIVE MINDS
CENTER ROAD SOLUTIONS
2 reports
ACURX PHARMACEUTICALS, INC.
INNOVATIVE FEDERAL STRATEGIES, LLC
2 reports
ADOBE SYSTEMS INC.
MEHLMAN CONSULTING, INC.
2 reports
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)
CROSSROADS STRATEGIES, LLC
2 reports
ALABAMA INSTITUTE FOR DEAF AND BLIND
CROSSROADS STRATEGIES, LLC
2 reports
ALBANY STATE UNIVERSITY
HOLLAND & KNIGHT LLP
2 reports
2 reports
2 reports
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY
VAN SCOYOC ASSOCIATES
2 reports
AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2 reports
AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE
VAN SCOYOC ASSOCIATES
2 reports
All 25 of 410 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| 3M COMPANY | 2 | $1.5M | Q2 2026 | Q3 2026 | yes | |
| ACTION NOW INITIATIVE, LLC | LEWIS-BURKE ASSOCIATES, LLC | 2 | $60K | Q2 2026 | Q3 2026 | yes |
| ACTIVE MINDS | CENTER ROAD SOLUTIONS | 2 | $80K | Q2 2026 | Q3 2026 | yes |
| ACURX PHARMACEUTICALS, INC. | INNOVATIVE FEDERAL STRATEGIES, LLC | 2 | $60K | Q2 2026 | Q3 2026 | yes |
| ADOBE SYSTEMS INC. | MEHLMAN CONSULTING, INC. | 2 | $120K | Q2 2026 | Q3 2026 | yes |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | CROSSROADS STRATEGIES, LLC | 2 | $100K | Q2 2026 | Q3 2026 | yes |
| ALABAMA INSTITUTE FOR DEAF AND BLIND | CROSSROADS STRATEGIES, LLC | 2 | $40K | Q2 2026 | Q3 2026 | yes |
| ALBANY STATE UNIVERSITY | HOLLAND & KNIGHT LLP | 2 | $40K | Q2 2026 | Q3 2026 | yes |
| ALKERMES, INC. | 2 | $1.9M | Q2 2026 | Q3 2026 | yes | |
| ALLIANCE FOR AGING RESEARCH | 2 | $135K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ACADEMY OF ADDICTION PSYCHIATRY | VAN SCOYOC ASSOCIATES | 2 | $60K | Q2 2026 | Q3 2026 | yes |
| AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2 | $675K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 2 | $100K | Q2 2026 | Q3 2026 | yes |
| AMERICAN ASSOCIATION FOR MARRIAGE AND FAMILY THERAPY | 2 | $40K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE | VAN SCOYOC ASSOCIATES | 2 | $40K | Q2 2026 | Q3 2026 | yes |
| AMERICAN ASSOCIATION OF COLLEGES OF NURSING | 2 | $180K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF COLLEGES OF NURSING | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 2 | $0 | Q2 2026 | Q3 2026 | yes |
| AMERICAN ASSOCIATION OF COLLEGES OF OSTEOPATHIC MEDICINE | CROSSROADS STRATEGIES, LLC | 2 | $0 | Q2 2026 | Q3 2026 | yes |
| AMERICAN ASSOCIATION OF COMMUNITY COLLEGES | 2 | $80K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF NURSE ANESTHETISTS | 2 | $515K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF NURSE ANESTHETISTS | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 2 | $0 | Q2 2026 | Q3 2026 | yes |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 2 | $790K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 2 | $0 | Q2 2026 | Q3 2026 | yes |
| AMERICAN COLLEGE OF CARDIOLOGY | 2 | $1.3M | Q2 2026 | Q3 2026 | yes | |
| AMERICAN COLLEGE OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (ACOEM) | VAN SCOYOC ASSOCIATES | 2 | $60K | Q2 2026 | Q3 2026 | yes |